Press Releases
Cenduit Showcases IRT Solutions at Clinical Trial Supply Europe
DURHAM, NC, UNITED STATES - Feb 18, 2015 - WHAT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at Clinical Trial Supply Europe, February 25-26 in Cannes, France. In addition, Cenduit senior product manager Caroline Ottmann will discuss electronic drug accountability systems in a presentation at the annual meeting. Attendees are invited to visit Cenduits booth (#59) to learn more.
Cenduit is excited to be a part of this years event and have the opportunity to showcase our companys commitment to deliver unprecedented support for clinical trials across the globe, said Ottmann. We live, sleep and breathe IRT with clinical trial experience spanning more than 16,000 sites and 100 countries internationally, and have the expertise to help sponsors increase efficiencies and reduce costs to get their drug to market faster.
WHO: Cenduit experts presenting at Clinical Trial Supply Europe:
- On February 26 at 11 a.m., Caroline Ottmann, senior product manager, will present, Increasing protocol compliance and trial data integrity through the use of electronic drug accountability systems.
Interview Opportunities: Caroline Ottmann
WHEN: February 25-26, 2015
WHERE: Grand Hyatt Cannes Hotel Martinez, 73 Boulevard de la Croisette, Cannes
Booth 59
DETAILS: For media inquiries, please contact Ryan Boger at Largemouth Communications, (919) 459-6481, ryan@largemouthpr.com.
ABOUT: Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, is the largest IRT specialist in the world with the expertise to empower sponsors for success by implementing a completely personalized system that puts them in control of their clinical trials. With the needs of investigator sites and patients top of mind, Cenduit offers clinical supply chain intelligence and clinical operations know-how through its IRT-driven services: patient randomization, patient reminders, drug supply management, and eClinical integration. Cenduit has offices in the US, UK, Switzerland, India, and Japan, and global clinical trial experience in more than 100 countries, interacting with more than 600,000 patients at more than 32,000 sites. For additional information, visit Cenduit online at www.cenduit.com; on Twitter @CenduitLLC or on LinkedIn at www.LinkedIn.com/Company/Cenduit.
